Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BN - FR0000120644 - Common Stock

76.88 EUR
+0.4 (+0.52%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

5

BN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 61 industry peers in the Food Products industry. While BN has a great profitability rating, there are quite some concerns on its financial health. BN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
BN had a positive operating cash flow in the past year.
BN had positive earnings in each of the past 5 years.
Each year in the past 5 years BN had a positive operating cash flow.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

BN has a Return On Assets of 4.20%. This is in the better half of the industry: BN outperforms 62.30% of its industry peers.
BN has a better Return On Equity (11.59%) than 63.93% of its industry peers.
BN has a Return On Invested Capital of 6.83%. This is in the better half of the industry: BN outperforms 63.93% of its industry peers.
BN had an Average Return On Invested Capital over the past 3 years of 6.38%. This is in line with the industry average of 7.37%.
The 3 year average ROIC (6.38%) for BN is below the current ROIC(6.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROIC 6.83%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BN has a better Profit Margin (6.72%) than 72.13% of its industry peers.
In the last couple of years the Profit Margin of BN has remained more or less at the same level.
BN has a better Operating Margin (13.25%) than 77.05% of its industry peers.
In the last couple of years the Operating Margin of BN has declined.
BN's Gross Margin of 50.47% is fine compared to the rest of the industry. BN outperforms 78.69% of its industry peers.
BN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

BN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BN has less shares outstanding
Compared to 1 year ago, BN has an improved debt to assets ratio.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.54 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of BN (2.54) is better than 62.30% of its industry peers.
BN has a debt to FCF ratio of 5.07. This is a neutral value as BN would need 5.07 years to pay back of all of its debts.
The Debt to FCF ratio of BN (5.07) is better than 72.13% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that BN is somewhat dependend on debt financing.
BN has a Debt to Equity ratio of 0.83. This is in the lower half of the industry: BN underperforms 67.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Altman-Z 2.54
ROIC/WACC1.06
WACC6.45%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

BN has a Current Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.95, BN is not doing good in the industry: 75.41% of the companies in the same industry are doing better.
BN has a Quick Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, BN is doing worse than 60.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.78
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.47%.
The Earnings Per Share has been decreasing by -1.17% on average over the past years.
BN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.54%.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.60% yearly.
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%

3.2 Future

The Earnings Per Share is expected to grow by 6.39% on average over the next years.
The Revenue is expected to grow by 3.16% on average over the next years.
EPS Next Y7.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
EPS Next 5Y6.39%
Revenue Next Year0.7%
Revenue Next 2Y1.88%
Revenue Next 3Y2.56%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated rather expensively with a Price/Earnings ratio of 20.56.
The rest of the industry has a similar Price/Earnings ratio as BN.
When comparing the Price/Earnings ratio of BN to the average of the S&P500 Index (26.59), we can say BN is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.36, BN is valued on the expensive side.
BN's Price/Forward Earnings ratio is in line with the industry average.
BN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.56
Fwd PE 18.36
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is in line with the industry average.
BN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 18.26
EV/EBITDA 11.04
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)2.57
PEG (5Y)N/A
EPS Next 2Y7.4%
EPS Next 3Y7.7%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.75%, BN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.34, BN pays a bit more dividend than its industry peers.
BN's Dividend Yield is a higher than the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 2.75%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years3
Div Non Decr Years4
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

74.99% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
The dividend of BN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP74.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (12/24/2025, 7:00:00 PM)

76.88

+0.4 (+0.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-07 2025-10-07
Earnings (Next)02-20 2026-02-20/amc
Inst Owners54.6%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap52.39B
Revenue(TTM)27.36B
Net Income(TTM)1.84B
Analysts74.84
Price Target80.89 (5.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.75%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP74.99%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.22%
PT rev (3m)4.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 20.56
Fwd PE 18.36
P/S 1.91
P/FCF 18.26
P/OCF 13.62
P/B 3.3
P/tB N/A
EV/EBITDA 11.04
EPS(TTM)3.74
EY4.86%
EPS(NY)4.19
Fwd EY5.45%
FCF(TTM)4.21
FCFY5.48%
OCF(TTM)5.64
OCFY7.34%
SpS40.15
BVpS23.28
TBVpS-9.5
PEG (NY)2.57
PEG (5Y)N/A
Graham Number44.26
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROCE 12.02%
ROIC 6.83%
ROICexc 8.36%
ROICexgc 50.58%
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
FCFM 10.49%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexgc growth 3Y19.7%
ROICexgc growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Debt/EBITDA 2.71
Cap/Depr 77.72%
Cap/Sales 3.57%
Interest Coverage 23.53
Cash Conversion 78.8%
Profit Quality 156.01%
Current Ratio 0.95
Quick Ratio 0.78
Altman-Z 2.54
F-Score8
WACC6.45%
ROIC/WACC1.06
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
EPS Next Y7.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
EPS Next 5Y6.39%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%
Revenue Next Year0.7%
Revenue Next 2Y1.88%
Revenue Next 3Y2.56%
Revenue Next 5Y3.16%
EBIT growth 1Y3.81%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year35.93%
EBIT Next 3Y14.73%
EBIT Next 5Y10.92%
FCF growth 1Y12.42%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y12.55%
OCF growth 3Y3.31%
OCF growth 5Y2.15%

DANONE / BN.PA FAQ

What is the ChartMill fundamental rating of DANONE (BN.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BN.PA.


Can you provide the valuation status for DANONE?

ChartMill assigns a valuation rating of 3 / 10 to DANONE (BN.PA). This can be considered as Overvalued.


Can you provide the profitability details for DANONE?

DANONE (BN.PA) has a profitability rating of 7 / 10.


How financially healthy is DANONE?

The financial health rating of DANONE (BN.PA) is 3 / 10.


How sustainable is the dividend of DANONE (BN.PA) stock?

The dividend rating of DANONE (BN.PA) is 5 / 10 and the dividend payout ratio is 74.99%.